Dr. Reddy’s receives EIR for API Mirfield Plant in UK

24 Apr 2018 Evaluate

Dr. Reddy’s Laboratories has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its API Mirfield Plant, United Kingdom (UK).

Recently, the company has received the EIR from the USFDA for its API Cuernavaca plant in Mexico.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

6266.50 13.25 (0.21%)
29-Apr-2024 11:17 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1522.00
Dr. Reddys Lab 6266.50
Cipla 1398.85
Zydus Lifesciences 962.15
Lupin 1633.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.